Skip to main content
Barry Feinberg, MD, Anesthesiology, Saint Louis, MO

BarryIFeinbergMD

Anesthesiology Saint Louis, MO

Pain Medicine

Physician

Dr. Feinberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Feinberg's full profile

Already have an account?

  • Office

    10435 Clayton Rd
    Ste 120
    Saint Louis, MO 63131
    Phone+1 314-985-3002
    Fax+1 314-985-3013

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Anesthesiology, 1981 - 1984
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Anesthesiology, 1980 - 1984
  • Zucker School of Medicine at Hofstra/Northwell at Staten Island University Hospital
    Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalInternship, Internal Medicine, 1980 - 1981
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 1980

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1992 - 2026
  • CO State Medical License
    CO State Medical License 2017 - 2025
  • MO State Medical License
    MO State Medical License 1986 - 2025
  • PA State Medical License
    PA State Medical License 1982 - 1986
  • American Board of Anesthesiology Anesthesiology
  • American Board of Anesthesiology Pain Medicine

Publications & Presentations

PubMed

Press Mentions

  • Janssen Announces Erdafitinib Improved Overall Survival Versus Chemotherapy in Patients with Metastatic or Unresectable Urothelial Carcinoma and Selected Fibroblast Growth Factor Receptor Gene Alterations After Prior Anti-PD-(L)1 Treatment
    Janssen Announces Erdafitinib Improved Overall Survival Versus Chemotherapy in Patients with Metastatic or Unresectable Urothelial Carcinoma and Selected Fibroblast Growth Factor Receptor Gene Alterations After Prior Anti-PD-(L)1 TreatmentJune 10th, 2023